Literature DB >> 4356004

Prevention of gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. I. Effect on the colonization pattern of the upper respiratory tract of seriously ill patients.

S Greenfield, D Teres, L S Bushnell, J Hedley-Whyte, D S Feingold.   

Abstract

A prospective study used polymyxin B by aerosol to reduce colonization of the upper respiratory tract with nosocomial gram-negative bacilli. 58 high-risk patients from the Respiratory-Surgical Intensive Care Unit entered the trial. 33 were randomly selected to receive 2.5 mg/kg/day of polymyxin B by hand atomizer into the pharynx, and tracheal tube if present. 17 of 25 control patients became colonized with gram-negative bacilli as compared with 7 of 33 polymyxin-treated patients (p < 0.01). Control patients became colonized with a total of 33 gram-negative bacilli: 3 were Pseudomonas aeruginosa, 21 were species of Enterobacteriaceae. The polymyxin-treated patients became colonized with a total of 11 gram-negative bacilli: no P. aeruginosa and only 3 species of Enterobacteriaceae were recovered. Colonization increased with duration in Respiratory-Surgical Intensive Care Unit and with time of required controlled ventilation. Polymyxin most effectively prevented the increase in colonization in treated patients who stayed in the Respiratory-Surgical Intensive Care Unit for longer than 1 wk and who required controlled ventilation for at least 72 h.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4356004      PMCID: PMC302562          DOI: 10.1172/JCI107490

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens.

Authors:  S Greenfield; D S Feingold
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

2.  Endobronchial Polymyxin B: experimental observations in chronic bronchitis.

Authors:  J Ramirez; E F O'Neill
Journal:  Chest       Date:  1970-10       Impact factor: 9.410

3.  Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli.

Authors:  W G Johanson; A K Pierce; J P Sanford
Journal:  N Engl J Med       Date:  1969-11-20       Impact factor: 91.245

4.  Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia.

Authors:  J R Tillotson; M Finland
Journal:  J Infect Dis       Date:  1969-06       Impact factor: 5.226

5.  Nonfermentative gram-negative bacilli of nosocomial interest.

Authors:  P Gardner; W B Griffin; M N Swartz; L J Kunz
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

6.  Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility.

Authors:  M M Pedersen; E Marso; M J Pickett
Journal:  Am J Clin Pathol       Date:  1970-08       Impact factor: 2.493

7.  Prediction of antimeningococcic chemoprophylactic efficacy.

Authors:  P D Hoeprich
Journal:  J Infect Dis       Date:  1971-02       Impact factor: 5.226

8.  Evaluation of sodium colistimethate aerosol in gram-negative infections of the respiratory tract.

Authors:  H D Rose; M B Pendharker; G L Snider; R C Kory
Journal:  J Clin Pharmacol J New Drugs       Date:  1970 Jul-Aug

9.  Mechanisms of antibacterial action in the respiratory system.

Authors:  E H Kass; G M Green; E Goldstein
Journal:  Bacteriol Rev       Date:  1966-09

10.  Quantitation of microorganisms in sputum.

Authors:  P W Monroe; H G Muchmore; F G Felton; J K Pirtle
Journal:  Appl Microbiol       Date:  1969-08
View more
  15 in total

1.  Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailability.

Authors:  F Bressolle; J E de la Coussaye; R Ayoub; D Fabre; R Gomeni; G Saissi; J J Eledjam; M Galtier
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

2.  Do microorganisms play a role in irradiation mucositis?

Authors:  H K van Saene; M V Martin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

3.  5-fluorocytosine and amphotericin B in bronchial secretions.

Authors:  J E Pennington; E R Block; H Y Reynolds
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

4.  Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patients.

Authors:  J M Klick; G C du Moulin; J Hedley-Whyte; D Teres; L S Bushnell; D S Feingold
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

Review 5.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Infection prevention by selective decontamination in intensive care.

Authors:  W G Johanson
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 7.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 8.  Nosocomial pneumonia in patients in intensive care units.

Authors:  S D Podnos; G B Toews; A K Pierce
Journal:  West J Med       Date:  1985-11

9.  Pneumonia prevention: a step backwards.

Authors:  W G Johanson
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

10.  Oropharyngeal flora as a source of bacteria colonizing the lower airways in patients on artificial ventilation.

Authors:  R van Uffelen; H K van Saene; V Fidler; A Löwenberg
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.